Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK/NF-κB/ERK signaling pathway

Haohui Guo, Dong Ding, Limei Wang, Jiangbo Yan, Long Ma, Qunhua Jin

Open source

DOI
10.1371/journal.pone.0261127
Published
2021-12-16
Container
PLOS ONE
Publisher
Public Library of Science (PLoS)
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0261127,
  title = {Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK/NF-κB/ERK signaling pathway},
  author = {Haohui Guo and Dong Ding and Limei Wang and Jiangbo Yan and Long Ma and Qunhua Jin},
  year = {2021},
  journal = {PLOS ONE},
  doi = {10.1371/journal.pone.0261127},
  url = {https://doi.org/10.1371/journal.pone.0261127}
}

RIS

TY  - JOUR
TI  - Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK/NF-κB/ERK signaling pathway
AU  - Haohui Guo
AU  - Dong Ding
AU  - Limei Wang
AU  - Jiangbo Yan
AU  - Long Ma
AU  - Qunhua Jin
PY  - 2021
JO  - PLOS ONE
DO  - 10.1371/journal.pone.0261127
UR  - https://doi.org/10.1371/journal.pone.0261127
ER  - 

APA

Guo, H., Ding, D., Wang, L., Yan, J., Ma, L., & Jin, Q. (2021). Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK/NF-κB/ERK signaling pathway. PLOS ONE. https://doi.org/10.1371/journal.pone.0261127

Source records